000 01660nam a22003617a 4500
001 43492
003 BD-DhAAL
005 20251224155048.0
008 241002t2024 enka rb 001 0 eng d
020 _a9780113231041
040 _aBD-DhAAL
_cBD-DhAAL
082 0 0 _a615.11
_223
245 0 0 _aBritish pharmacopoeia
_f2025.
_nVolume V.
260 _aLondon :
_bThe Stationery Office,
_c2025.
300 _aV-vii, V-1060 pages :
_billustrations ;
_c31 cm.
362 _aVol. 5
500 _aEffective date 1st January 2025.
500 _aIncorporating the requirements of the 11th edition of the European Pharmacopoeia as amended by Supplements 11.1 to 11.5.
504 _aIncludes bibliographical references and index.
505 0 _av. 5. Notices -- General notices -- Infrared reference spectra -- Appendices -- Supplementary chapters -- Index.
526 _aPHR
650 0 _aPharmacopoeias.
_944450
650 0 _aPharmacopoeias
_zGreat Britain.
650 0 _aDrugs
_xStandards
_zGreat Britain.
_944451
650 0 _aPharmacy.
_944452
710 _aGreat Britain.
_bDepartment of Health & Social Care.
_959992
710 _aNorthern Ireland.
_bDepartment of Health (HI).
_959995
710 _aGreat Britain.
_bMedicines and Healthcare products Regulatory Agency.
_959993
710 _aBritish Pharmacopoeia Commission.
_959994
942 _2ddc
_cBK
999 _c46916
_d46916